The Relative Strength (RS) Rating for Genpact climbed into a new percentile Friday, with a rise from 77 to 83.
This proprietary rating tracks technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Decades of market research reveals that the stocks that go on to make the biggest gains often have an 80 or better RS Rating as they begin their biggest runs.
Hone Your Stock-Picking Skills By Focusing On These Factors
Genpact has moved more than 5% past a 39.95 entry in a first-stage flat base, meaning it's now out of a proper buy zone. Look for the stock to create a new buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week moving average.
Regarding fundamentals, the company has posted rising EPS growth over the last two quarters. Top line growth has also increased during the same period.
The company earns the No. 5 rank among its peers in the Commercial Services-Outsourcing industry group. ExlService Holdings is the top-ranked stock within the group.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
